Fulderm Sweden

Fulderm Sweden is a specialty pharmaceutical company based in Stockholm, Sweden, that focuses on the development and commercialization of dermatological products. The company's primary offering is Fulderm, a topical solution containing a combination of fluorouracil and salicylic acid designed to treat actinic keratosis. By targeting pre-cancerous skin lesions with a potent antimetabolite and a keratolytic agent, the company provides an effective outpatient therapy for a common dermatological condition. Fulderm Sweden manages the regulatory, marketing, and distribution activities for its portfolio within the Nordic region. The company was founded by industry veterans with significant experience in the Swedish life sciences sector and aims to improve patient outcomes through optimized formulations of established therapeutic agents.